Acute Myelogenous Leukemia  >>  tirbanibulin oral (KX2-391 oral)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tirbanibulin oral (KX2-391 oral) / Hanmi, Athenex
NCT01397799: Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)

Completed
1b
24
US
KX2-391, KX01
Kinex Pharmaceuticals Inc.
Acute Myelogenous Leukemia
07/14
07/14

Download Options